Literature DB >> 19809938

Charcot-Marie-Tooth (CMT) disease 1A with superimposed inflammatory polyneuropathy in children.

A Desurkar1, J-P Lin, K Mills, S Al-Sarraj, W Jan, H Jungbluth, E Wraige.   

Abstract

Charcot-Marie-Tooth (CMT) disease is genetically heterogeneous and subdivided into demyelinating (CMT 1) and axonal (CMT 2) types based on neurophysiology findings. CMT1A, the commonest form associated with duplication of the PMP22 segment on chromosome 17p, often arises in childhood but is generally a slowly progressive disease. We report 2 children presenting with clinical features of an acute inflammatory demyelinating polyneuropathy (AIDP) who were subsequently diagnosed with underlying CMT1A. Both children had neurophysiology and histopathology features consistent with CMT1. Immunoglobulin treatment was initiated considering the evidence of superimposed inflammation and appeared to modify disease progression. Our findings indicate that CMT1A predisposes to a superimposed inflammatory neuropathy. Recognition of this association is difficult, particularly in children without clear family history, but of great importance as immunomodulatory treatment may improve outcome. In addition, we postulate that an underlying genetic polyneuropathy should be suspected if the recovery from AIDP is slower than expected, or incomplete. (c) Georg Thieme Verlag KG Stuttgart, New York.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19809938     DOI: 10.1055/s-0029-1237720

Source DB:  PubMed          Journal:  Neuropediatrics        ISSN: 0174-304X            Impact factor:   1.947


  4 in total

Review 1.  A review of the role of genetic factors in Guillain-Barré syndrome.

Authors:  Amin Safa; Tahereh Azimi; Arezou Sayad; Mohammad Taheri; Soudeh Ghafouri-Fard
Journal:  J Mol Neurosci       Date:  2020-10-07       Impact factor: 3.444

2.  AAV1.NT-3 gene therapy attenuates spontaneous autoimmune peripheral polyneuropathy.

Authors:  M E Yalvac; W D Arnold; C Braganza; L Chen; J R Mendell; Z Sahenk
Journal:  Gene Ther       Date:  2015-06-30       Impact factor: 5.250

3.  An n-of-one RCT for intravenous immunoglobulin G for inflammation in hereditary neuropathy with liability to pressure palsy (HNPP).

Authors:  Charlotte Vrinten; Xin Gu; Stephanie S Weinreich; Mirjam H Schipper; Judith Wessels; Michel D Ferrari; Herbert Hoijtink; Jan J G M Verschuuren
Journal:  J Neurol Neurosurg Psychiatry       Date:  2015-07-17       Impact factor: 10.154

4.  Melatonin Treatment Reduces Oxidative Damage and Normalizes Plasma Pro-Inflammatory Cytokines in Patients Suffering from Charcot-Marie-Tooth Neuropathy: A Pilot Study in Three Children.

Authors:  Mariam Chahbouni; María Del Señor López; Antonio Molina-Carballo; Tomás de Haro; Antonio Muñoz-Hoyos; Marisol Fernández-Ortiz; Ana Guerra-Librero; Darío Acuña-Castroviejo
Journal:  Molecules       Date:  2017-10-14       Impact factor: 4.411

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.